IP Verse

Virion-Like Delivery Particles For Self-Replicating Rna Molecules - EP4005592B1

PatentPatent Analysis

EP4005592

GLAXOSMITHKLINE
Application Number
EP21204155A
Filing Date
Jul 6, 2011
Status
Granted And Under Opposition
Sep 9, 2022
Grant Date
Oct 12, 2022
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP4226941B1
EP3682884B1
EP3480209B1

Bibliography

The patent EP4005592B1 was granted to Glaxosmithkline on Oct 12, 2022 following the initial filing on Jul 6, 2011 under the application number EP21204155A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

MARGARET DIXONJul 12, 2023ADMISSIBLE
THOMANNJul 11, 2023ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents